Genelux appoints Jodi Devlin as president
This article was originally published in Scrip
Executive Summary
Genelux, a San Diego-based biopharmaceutical company developing therapies against cancer, has appointed Jodi Devlin president. Dr Aladar Szalay, the company's founder, will continue to serve as CEO and chairman. Ms Devlin was most recently vice-president at Abbott, where she led the company's global pipeline marketing for all therapeutic areas. She also previously held the positions of vice-president of international marketing, US speciality operations, primary care and virology.